Blockers of the Kv1.5 channel for the treatment of atrial arrhythmias

被引：12
|
作者：
Brendel, J [1 ]
Peukert, S [1 ]
机构：
[1] Aventis Pharma Deutschland GMBH, Med Chem, D-65926 Frankfurt, Germany
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 2002年 / 12卷 / 11期
关键词：
arrhythmia; atrial fibrillation; IKur; Kv1.5; potassium channel blockers;
D O I：
10.1517/13543776.12.11.1589
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Atrial arrhythmias are a common problem in cardiological practice. Despite the availability of several antiarrhythmic drugs there is a medical need for safer and more efficient treatments. The voltage-gated potassium channel Kv1.5 is regarded as a promising target for the development of new atrial selective drugs with fewer side effects. This review summarises patents claiming such compounds.-The chemistry and biological data disclosed in these patents are discussed in light of recent work demonstrating the antiarrhythmic effects of Kv1.5 blockers in vivo.
引用
收藏
页码：1589 / 1598
页数：10
相关论文
共 50 条
  • [41] Pharmacophore-based search, synthesis, and biological evaluation of anthranilic amides as novel blockers of the Kv1.5 channel
    Peukert, S
    Brendel, J
    Pirard, B
    Strübing, C
    Kleemann, HW
    Böhme, T
    Hemmerle, H
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (11) : 2823 - 2827
  • [42] Synthesis and evaluation of (2-phenethyl-2H-1,2,3-triazol-4-yl)(phenyl)methanones as Kv1.5 channel blockers for the treatment of atrial fibrillation
    Blass, Benjamin E.
    Coburn, Keith
    Lee, Wenlin
    Fairweather, Nell
    Fluxe, Andrew
    Wu, Shengde
    Janusz, John M.
    Murawsky, Michael
    Fadayel, Gina M.
    Fang, Bin
    Hare, Michelle
    Ridgeway, Jim
    White, Ron
    Jackson, Chris
    Djandjighian, Laurent
    Hedges, Richard
    Wireko, Fred C.
    Ritter, Amanda L.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (17) : 4629 - 4632
  • [43] K+-dependent potentiation of currents in the Kv1.5 K+ channel:: Dependence on external pH and internal channel blockers
    Trapani, JG
    Andalib, P
    Korn, SJ
    BIOPHYSICAL JOURNAL, 2001, 80 (01) : 442A - 443A
  • [44] Role of caveolae for K+ channel (KV1.5) function
    Jürgens, S
    Drab, M
    Wettwer, E
    Ravens, U
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 : R66 - R66
  • [45] Presence of the Kv1.5 K+ channel in the sinoatrial node
    Dobrzynski, H
    Rothery, SM
    Marples, DDR
    Coppen, SR
    Takagishi, Y
    Honjo, H
    Tamkun, MM
    Henderson, Z
    Kodama, I
    Severs, NJ
    Boyett, MR
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2000, 48 (06) : 769 - 780
  • [46] Stabilization of Kv1.5 channel protein by the inotropic agent olprinone
    Endo, Ryo
    Kurata, Yasutaka
    Notsu, Tomomi
    Li, Peili
    Morikawa, Kumi
    Kondo, Takehito
    Ogura, Kazuyoshi
    Miake, Junichiro
    Yoshida, Akio
    Shirayoshi, Yasuaki
    Ninomiya, Haruaki
    Higaki, Katsumi
    Kuwabara, Masanari
    Yamamoto, Kazuhiro
    Inagaki, Yoshimi
    Hisatome, Ichiro
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 765 : 488 - 494
  • [47] Aryl sulfonamido indane inhibitors of the Kv1.5 ion channel
    Gross, Michael F.
    Beaudoin, Serge
    McNaughton-Smith, Grant
    Amato, George S.
    Castle, Neil A.
    Huang, Christine
    Zou, Anruo
    Yu, Weifeng
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (10) : 2849 - 2853
  • [48] Modulation of Kv1.5 potassium channel gating by extracellular zinc
    Zhang, ST
    Kehl, SJ
    Fedida, D
    BIOPHYSICAL JOURNAL, 2001, 81 (01) : 125 - 136
  • [49] Effect of external pH on activation of the Kv1.5 potassium channel
    Trapani, JG
    Korn, SJ
    BIOPHYSICAL JOURNAL, 2003, 84 (01) : 195 - 204
  • [50] Antiarrhythmic Drug-Induced Internalization of the Atrial-Specific K+ Channel Kv1.5
    Schumacher, Sarah M.
    McEwen, Dyke P.
    Zhang, Lian
    Arendt, Kristin L.
    Van Genderen, Kristin M.
    Martens, Jeffrey R.
    CIRCULATION RESEARCH, 2009, 104 (12) : 1390 - U284
12345